Augmedix Q3 EPS $(0.10) Beats $(0.12) Estimate, Sales $11.77M Beat $11.42M Estimate
Portfolio Pulse from mahesh@benzinga.com
Augmedix reported Q3 earnings per share (EPS) of $(0.10), beating the analyst consensus estimate of $(0.12) by 16.67%. This is a 33.33% increase over losses from the same period last year. The company also reported quarterly sales of $11.77 million, beating the analyst consensus estimate of $11.42 million by 3.04%. This is a 49.63% increase over sales from the same period last year.
November 06, 2023 | 9:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Augmedix's Q3 earnings and sales beat analyst estimates, indicating a positive financial performance.
Augmedix's Q3 earnings and sales exceeded analyst estimates, which is typically a positive signal for the company's financial performance and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100